5 hours ago · In New Dementia Trials, Ozempic’s ‘Miracle Drug’ Image Takes a Hit The drug failed to slow the progression of early Alzheimer’s. Experts are trying to understand why.

Dec 8, 2025 · The two new GLP-1 trials, called evoke and evoke+, included nearly 4,000 people with early-stage Alzheimer’s.

Nov 26, 2025 · Novo Nordisk won't add Alzheimer's disease to the list of conditions its blockbuster diabetes and weight-loss drugs, Ozempic and Wegovy, can treat, despite high hopes and two years …

Nov 24, 2025 · The company’s pill-based version of Ozempic — part of a bold attempt to explore whether GLP-1 drugs could treat Alzheimer’s disease — has failed in a long-shot clinical effort, …

15 hours ago · The drug failed to slow the progression of early Alzheimer’s. Experts are trying to understand why.

Jun 3, 2025 · Dozens of breakthrough drug trials, including one using the main ingredient in weight-loss jabs, offer patients “hope” for the treatment and prevention of dementia and Alzheimer’s disease.

Apr 10, 2025 · In a remarkable twist that’s reshaping how we think about some of today’s most popular diabetes drugs, medications like Ozempic and Wegovy —known scientifically as GLP-1 receptor …